Literature DB >> 30575141

Senescent fibroblasts in melasma pathophysiology.

Misun Kim1, So Min Kim1, Soohyun Kwon1, Tae Jun Park2,3,4, Hee Young Kang1,4.   

Abstract

It has been proposed that melasma is a photoageing skin disorder. The photoaged fibroblasts have been suggested as an important source of melanogenic factors which are involved in the regulation of pigmentation. To investigate whether melasma includes senescent cells, lesional and perilesional normal skin from 38 melasma patients was assessed using a cell senescence marker, p16INK4A . The results showed that lesional dermal skin had more p16INK4A -positive senescent cells than perilesional skin. The impact of senescent fibroblasts was further investigated in a pilot study using radiofrequency (RF) intervention for melasma. It showed that the RF therapy decreased the number of senescent cells with increased expression of procollagen-1, which were associated with reduced epidermal pigmentation. This leads us to the speculation that senescent fibroblasts may contribute to drive melasma and might be considered as a potential therapeutic target.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  melasma; photoageing; radiofrequency; senescent fibroblasts

Year:  2018        PMID: 30575141     DOI: 10.1111/exd.13814

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

2.  Proteomic study of facial melasma.

Authors:  Luiza Vasconcelos Schaefer; Leticia Gomes de Pontes; Nayara Rodrigues Vieira Cavassan; Lucilene Delazari Dos Santos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-09-10       Impact factor: 2.113

Review 3.  Focus on the Contribution of Oxidative Stress in Skin Aging.

Authors:  Federica Papaccio; Andrea D Arino; Silvia Caputo; Barbara Bellei
Journal:  Antioxidants (Basel)       Date:  2022-06-06

Review 4.  New and Emerging Therapies for Alopecia Areata.

Authors:  Aunna Pourang; Natasha Atanaskova Mesinkovska
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

Review 5.  Dermal Pathology in Melasma: An Update Review.

Authors:  Kachanat Phansuk; Vasanop Vachiramon; Natthachat Jurairattanaporn; Kumutnart Chanprapaph; Teerapong Rattananukrom
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-06

Review 6.  Update on Melasma-Part I: Pathogenesis.

Authors:  Ana Cláudia C Espósito; Daniel P Cassiano; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Ediléia Bagatin; Luciane D B Miot; Hélio Amante Miot
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29

7.  Fibroblast morphology, growth rate and gene expression in facial melasma.

Authors:  Ana Cláudia Cavalcante Espósito; Gabrielli Brianezi; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-07-12       Impact factor: 2.113

Review 8.  Skin-Aging Pigmentation: Who Is the Real Enemy?

Authors:  Jin Cheol Kim; Tae Jun Park; Hee Young Kang
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

Review 9.  Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.

Authors:  Zuzanna Piętowska; Danuta Nowicka; Jacek C Szepietowski
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.